Microsoft Word - SET-AIS-CP 007-2020 Acquisition of spectrum license.docx (Translation) AIS-CP 007/2020 19 February 2020 Subject: Acquisition of spectrum license To: President The Stock Exchange of
RISK SPECTRUM ของประเภทตราสารที่ลงทุน ความเสี่ยง/มีความซับซ้อนต่ำ ความเสี่ยง/มีความซับซ้อนสูง กองทุนรวม กองทุนรวม กองทุนรวม กองทุนรวม กองทุนรวมผสม กองทุนรวม กองทุนรวม กองทุนรวมที่ลงทุนใน ตลาดเงิน
burden to investors, which could develop into an obstacle for accessing investment services and products in the capital market. SEC therefore is proposing the regulations on the use of a single form for
, derivatives fund manager, investor contact and derivatives investor contact shall receive an approval from the SEC Office and whereas the flood catastrophe may cause obstacle and inconvenience to such persons
Assets by Subsidiary of DOD Biotech Public Company Limited for the Purchase and Acceptance of Transfer of the Entire Business of BGP Spectrum Power Co., Ltd., and Establishment of Subsidiary, Classified as
continued to expand and improve network quality with new 2600MHz spectrum and enhance 4G/5G network capacity to secure leading position. As a result, EBITDA (Pre-TFRS16) decreased -3.0%YoY, in line with FY20
. As a result, EBITDA in 1H21 increased by 1.1%YoY despite soften core service revenue, offset by cost control in SG&A. With the 700MHz spectrum license and 26GHz spectrum license acquired in 1H21, D&A
Bt6,311mn, -5.0% YoY and -8.1% QoQ. Excluding unrealized FX loss, normalized NPAT was 6,345mn, -7.0% YoY due to higher spectrum amortization and -5.8% QoQ from lower core service revenue. The full- year
was Bt6,644mn, decreasing -1.7%YoY as D&A rose from new spectrum and expansion and decreasing -7.3%QoQ from unrealized foreign exchange loss and tax benefit in 4Q20. Market and Competitive Environment